期刊
ONCOGENE
卷 27, 期 39, 页码 5169-5181出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2008.148
关键词
cell adhesion-mediated drug resistance; glioblastoma; apoptosis
资金
- Deutsche Forschungsgemeinschaft
- Deutsche Krebshilfe
- Ministry of Science
- Research and Arts of Baden-Wurttemberg
- IZKF Ulm
- Wilhelm-Sander-Stiftung
- Else-Kroner-Fresenius-Stiftung
The failure of malignant cells to undergo apoptosis is a major obstacle in cancer therapy, and thus identifying the underlining molecules involved therein is imperative for improving patient survival. An important mechanism of drug resistance is cell adhesion-mediated drug resistance (CAM-DR). In this study we identify a novel switch by which glioblastoma multiforme (GBM) cells alter the mode of CAM-DR. In the absence of a microenvironmental cue provided by components of the extracellular matrix (ECM), GBM cells are able to employ an alternative, but equally effective, mode of CAM-DR by forming spheres via cell-cell interactions. Intriguingly, when inhibiting cell-cell interactions in the absence of ECM components, either by low cell density or by inhibition of gap junctions (intercellular connexin tunnels) through chemical inhibition with carbenoxyolone or coincubation with the connexin-mimicking Gap27 Cx37,43 peptide, GBM cells were sensitized to tumor necrosis factor-related apoptosis- inducing ligand- and CD95-induced apoptosis. By demonstrating that GBM cells can alternate from one form of CAM-DR (cell-substrate tethering) to another (homocellular cell-cell adhesion) and that inhibition of both forms is necessary for apoptosis sensitization, our findings not only have important implications for novel approaches to restore defective apoptosis programs, but also reveal a novel role of gap junctions in GBM.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据